Sale of Gerber to Nestlé will allow Novartis 'to focus on its pharmaceuticals'
Novartis has agreed to sell its Gerber baby foods business to Nestlé for $5.5 billion in cash, so completing the company's divestiture program and allowing it to focus on healthcare with pharmaceuticals at the core.
Dr. Daniel Vasella, Chairman and CEO of Novartis, considers the sale as, "the right move for Gerber, as it will become a priority business in a leading global nutrition company."
Keywords : Novartis, Switzerland Gerber brand, Baby foods, Nutrition, Divestiture
